Adolescent Cardiomyopathy Breakthrough
Cardiac myosin inhibitors show promise for adolescents with obstructive hypertrophic cardiomyopathy, reducing LVOT obstruction and signaling disease-modifying therapy that may lessen symptoms and invasive procedures.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.